Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2008
08/14/2008US20080193393 Delivery System for Topically Applied Compounds
08/14/2008US20080193385 Compositions and methods for treating neuropathy
08/14/2008US20080193383 administering delta receptor angonists such as diarylmethyl piperazine and diarylmethyl piperidine compounds; side effect reduction of anesthetics, barbiturates and analgesics
08/14/2008US20080193382 preventing or delaying development or progression of a condition associated with inflammation caused by necrosis, comprising administering drugs that inhibits interleukin signalling
08/14/2008US20080193381 Heterodimers of glutamic acid
08/14/2008DE202008006245U1 Zusammensetzung für die medizinische Anwendung, insbesondere Antazidum A composition for medical use, in particular antacid
08/14/2008DE202007015195U1 Korianderöl-Fraktionen enthaltende Zubereitungen und deren Verwendung zur Herstellung eines Arzneimittels oder kosmetischen Mittels Coriander oil fractions containing preparations and their use for the manufacture of a medicament or cosmetic agent
08/14/2008CA2700585A1 Food extracts for treatment of lipoprotein abnormalities and skin diseases and skin disorders
08/14/2008CA2678258A1 Treprostinil treatment for interstitial lung disease and asthma
08/14/2008CA2678255A1 Inhibitors of akt activity
08/14/2008CA2678193A1 Aza-bridged-ring compound
08/14/2008CA2677995A1 Acylguanidine derivative
08/14/2008CA2677838A1 Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile
08/14/2008CA2677798A1 Treatment of resistant or refractory cancers with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin
08/14/2008CA2677695A1 Use of flibanserin for the treatment of insomnia
08/14/2008CA2677661A1 Tricyclic compounds
08/14/2008CA2677657A1 Agent for preventing bleeding from cerebral cortical vein
08/14/2008CA2677640A1 Stabilized picoplatin oral dosage form
08/14/2008CA2677639A1 Encapsulated picoplatin
08/14/2008CA2677631A1 Olopatadine formulations for topical nasal administration
08/14/2008CA2677493A1 Pyridopyrimidinone compounds useful in treating sodium channel-mediated diseases or conditions
08/14/2008CA2677487A1 Compounds and compositions as channel activating protease inhibitors
08/14/2008CA2677485A1 Compounds and compositions as channel activating protease inhibitors
08/14/2008CA2677481A1 Triazole compounds that modulate hsp90 activity
08/14/2008CA2677457A1 New compounds, methods for their preparation and use thereof
08/14/2008CA2677442A1 Nitric oxide releasing steroids
08/14/2008CA2677441A1 Nitric oxide releasing steroids
08/14/2008CA2677437A1 Heterocyclyl substituted tetrahydronaphthalene derivatives as 5-ht7 receptor ligands
08/14/2008CA2677387A1 Nitric oxide donor compounds
08/14/2008CA2677365A1 2-amino-5, 7-dihydro-6h-pyrrolo [3, 4-d] pyrimidine derivatives as hsp- 90 inhibitors for treating cancer
08/14/2008CA2677354A1 Progesterone for the treatment or prevention of spontaneous preterm birth
08/14/2008CA2677347A1 Stable pharmaceutical drug aerosols
08/14/2008CA2677336A1 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, the use thereof and processes for the preparation thereof
08/14/2008CA2677310A1 Methods for treating diseases of altered ige regulation
08/14/2008CA2677296A1 Therapeutic agents
08/14/2008CA2677290A1 Nitric oxide releasing steroids
08/14/2008CA2677273A1 Use of a composition comprising a cytokine encoding nucleic acid for treating alzheimer's disease
08/14/2008CA2677264A1 Compositions and methods for the treatment of metabolic disorders
08/14/2008CA2677263A1 Compounds and compositions as modulators of gpr119 activity
08/14/2008CA2677241A1 Compounds that inhibit cholinesterase
08/14/2008CA2677230A1 Use of a trpm5 inhibitor to regulate insulin and glp-1 release
08/14/2008CA2677026A1 An analgesic composition for neuropathic pain diseases containing n-acetylneuraminic acid
08/14/2008CA2677015A1 Hcv inhibiting macrocyclic phenylcarbamates
08/14/2008CA2676832A1 High-dose, long-acting ectoparasiticide for extended control
08/14/2008CA2676678A1 (indol-4-yl)- or (indol-5-yl)-piperazinylmethanone derivatives for the treatment of obesity
08/14/2008CA2676498A1 [1,2,3] triazolyl substituted quinolines and coumarins as inhibitors of leukotriene biosynthesis
08/14/2008CA2676422A1 Oxabicycloheptane and oxabicycloheptene phosphatase inhibitors, their preparation and use
08/14/2008CA2676300A1 Cellulose derivative and method for production thereof
08/14/2008CA2676268A1 5 -amido- (ih- indol- 2 -yl) piperazin-1-yl-methanone derivatives as histamine h3 receptor ligands
08/14/2008CA2676265A1 Indol-2-yl-piperazin-1-yl-methanone derivatives
08/14/2008CA2676145A1 1-benzenesulfonyl-1h-indole derivatives as inhibitors of ccr9 activity
08/14/2008CA2676139A1 Composition comprising terpene compounds and methods for inhibiting nerve transmission
08/14/2008CA2676081A1 Solvating system and sealant for medical use
08/14/2008CA2675994A1 Salts 668
08/14/2008CA2675629A1 New salt
08/14/2008CA2675558A1 Pi 3-kinase inhibitors and methods of their use
08/14/2008CA2675465A1 Combinations of beta- 2 -adrenoceptor agonistic benzothiazolone
08/14/2008CA2675462A1 Novel nucleoside analogs for treatment of viral infections
08/14/2008CA2675357A1 6-benzyl-2,3,4,7-tetrahydro-indolo [2, 3-c] quinoline compounds useful as pde5 inhibitors
08/14/2008CA2674014A1 Use of riluzole and derivatives thereof for producing new drugs
08/14/2008CA2664444A1 Use of oritavancin for prevention and treatment of anthrax
08/13/2008EP1956093A1 von Willebrand Factor (vWF)-cleaving protease
08/13/2008EP1956090A1 Novel protein and dna encoding the protein
08/13/2008EP1956030A1 Secreted and transmembrane polypeptides and nucleic acids endoding the same
08/13/2008EP1956021A1 Process for the manufacture of a crystalline pyrazolo[1,5-a]pyrimidine compound
08/13/2008EP1956020A2 1-[2-(heterocyclyl-aminomethyl)-piperidin-1-YL]-1-(2-methyl-5-phenyl-heterocyclyl)-methanone derivatives and related compounds as orexin-1 antagonists for the treatment of obesity
08/13/2008EP1956019A1 Benzoquinazoline derivatives
08/13/2008EP1956017A1 Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and method of reducing TNF alpha levels
08/13/2008EP1956016A1 Bicyclic acyltryptophanols
08/13/2008EP1956015A2 Polymorph of 2-(3-cyano-4-isobutyloxyphenyl)-4-methyl-5-thiazolecarboxylic acid and method of producing the same
08/13/2008EP1956014A2 Polymorphs of 2-(3-cyano-4-isobutyloxyphenyl)-4-methyl-5-thiazolecarboxylic acid and method of producing the same
08/13/2008EP1956013A1 Diagnostic and remedy for disease caused by amyloid aggregation and/or deposition
08/13/2008EP1956010A1 Bicyclical heterocycles, medicines containing these compounds, their application and method for their production
08/13/2008EP1956009A1 Aromatic compound
08/13/2008EP1956006A1 Heterocyclyl-substituted-tetrahydro-naphthalen derivatives as 5-HT7 receptor ligands
08/13/2008EP1956005A1 Delta d Crystaline form of ivabradine hydrochloride, process of preparation thereof and pharmaceutical compositions containing the same
08/13/2008EP1956004A1 Quinoline derivatives and their use as 5-HT6 ligands
08/13/2008EP1956002A1 New tegaserod maleate polymorphs and process for their preparation
08/13/2008EP1956001A1 Pharmaceutical for use in the treatment of ureterolithiasis
08/13/2008EP1955996A1 7, 9-Substituted tetracycline compounds
08/13/2008EP1955708A1 Novel memory ctl induction potentiator
08/13/2008EP1955707A1 Pharmaceutical composition for prevention or treatment of neurogenic pain
08/13/2008EP1955706A1 Interferon-alpha and c-phycocyanin for the treatment of autoimmune diseases, allergic diseases and cancer
08/13/2008EP1955703A1 Viruses for the treatment of cellular proliferative disorders
08/13/2008EP1955701A1 Polyacetylenic compounds
08/13/2008EP1955700A2 Therapeutic treatment of androgen receptor driven conditions
08/13/2008EP1955699A1 Use of flibanserin for the treatment of insomnia
08/13/2008EP1955698A1 Preventive/therapeutic agent for alzheimer's dementia
08/13/2008EP1955697A1 2-aminobenzamide derivative
08/13/2008EP1955696A2 Use of EDG receptor binding agents in cancer
08/13/2008EP1955694A1 HFC solution formulations containing an anticholinergic
08/13/2008EP1955693A1 Composition comprising chitosan and an acidic drug for oral controlled release
08/13/2008EP1955594A1 Antiseptic compositions and methods
08/13/2008EP1954836A2 Immunosuppression compound and treatment method
08/13/2008EP1954699A1 PYRIDO-,PYRAZO- AND PYRIMIDO-PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS
08/13/2008EP1954698A1 Spirocyclic compounds as hdac inhibitors
08/13/2008EP1954697A2 Peri condensed tricyclic compounds useful as antibacterial agents
08/13/2008EP1954694A1 Imidazole derivatives as nitric oxide synthase dimerisation inhibitor
08/13/2008EP1954693A1 Beta-secretase modulators and methods of use
08/13/2008EP1954692A1 Heterocycle-substituted 3-alkyl azetidine derivatives
1 ... 3135 3136 3137 3138 3139 3140 3141 3142 3143 3144 3145 3146 3147 3148 3149 3150 3151 3152 3153 3154 3155 ... 7860